ArticleUpdates in surgery2026
Is there a role for minor resections in perihilar cholangiocarcinoma? Single institutional results from a western center.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In perihilar cholangiocarcinoma major liver resections are often required to attain oncological radicality, but these approaches are associated with a high perioperative morbidity and mortality. The aim of this study was to assess the outcome of minor resections compared to standard major liver resections. A single-institutional database was queried for all patients undergoing resection for perihilar cholangiocarcinoma between 2008 and 2024. Minor resections were defined as resections of the hilar bifurcation including up to three liver segments, whereas major resections exceeded 3 segments. The primary study endpoint was safety and feasibility of resection represented by 30-day mortality. Secondary endpoints included survival outcomes. The primary outcome was evaluated using logistic regression. Survival outcomes were analysed using Kaplan-Meier method and Cox regression. Additionally, a propensity score matching was conducted, grouping variables by age and Bismuth-Classification. Two hundred sixteen patients underwent resection, 182 in the major resection and 34 in the minor resection group. Patients in the minor resection group were older (71.4 vs. 66.0 years, p = 0.007) and had more comorbidities (Charlson Comorbidity Index: 5.3 vs. 4.7, p = 0.03). After propensity score matching demographic data were balanced between groups. Minor resection was consistently associated with a trend toward lower 30-day mortality rate (2.9% vs. 13.7%, p = 0.057). Intraoperative blood loss requiring blood transfusion and length of surgery were independently associated with 30-day mortality, both of which were significantly lower in the minor resection group. Median overall survival was 30.1 months in the minor resection and 23.9 months in the major resection group (p = 0.84). Minor resection in perihilar cholangiocarcinoma was associated with a trend towards reduced and acceptable perioperative mortality at the expense of a lower surgical radicality and long-term survival compared to major resections.
Indexed as
Identifiers
42479127What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.